The finding, reported Oct. 8, 2013, at the AIDS Vaccine 2013 meeting in Barcelona, Spain, examined samples from two previously completed pediatric HIV vaccine trials -- called PACTG 230 and PACTG 326 -- to determine whether they elicited a key immune response that has only recently been associated with reduced HIV infection.
http://www.sciencedaily.com/releases/2013/10/131008142158.htm?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine%2Fvaccines+%28ScienceDaily%3A+Health+%26+Medicine+News+--+Vaccines%29
http://www.sciencedaily.com/releases/2013/10/131008142158.htm?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+sciencedaily%2Fhealth_medicine%2Fvaccines+%28ScienceDaily%3A+Health+%26+Medicine+News+--+Vaccines%29
No comments:
Post a Comment